Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Drug
Luye Pharma’s Goserelin Acetate Injectable Accepted for Breast Cancer Review
February 15, 2025
Company
Deals
Healthnice Pharma Raises RMB100m to Expand Product Pipeline and R&D Team
February 15, 2025
Company
Deals
Healthnice Pharma Raises RMB100m to Expand Product Pipeline and R&D Team
February 15, 2025
Company
Deals
Gilead Transfers Trodelvy Asian Rights to Everest Medicines for USD280m
February 15, 2025
Company
Drug
CDE Prioritizes Review for Sanofi’s Nexviazyme and WinHealth’s Ravicti
February 15, 2025
Company
Drug
Henlius Biotech’s HanBeiTai sBLA Accepted for HCC Treatment Review
February 15, 2025
Company
Drug
Alphamab Oncology Doses First Patient in KN046-209 Study for NSCLC
February 16, 2025
Company
Drug
Roche’s Rozlytrek Wins NMPA Approval for ROS1+ NSCLC Treatment
February 15, 2025
Company
EQRx Accelerates US Development of Two Chinese-Licensed Cancer Drugs
February 15, 2025
Company
Novartis Aims for China to Be Second – Largest Market by 2024
February 15, 2025
Company
Deals
ESR Group Enters Life Sciences with Zhangjiang NEO Acquisition
February 15, 2025
Company
Deals
ClouDr Partners with Ipsen to Expand Diphereline’s Reach in China
February 15, 2025
1
2
…
1,152
1,153
1,154
1,155
1,156
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
